Results 11 to 20 of about 580,459 (300)

Blood stem cell collections after mobilization with combination chemotherapy containing ifosfamide followed by G-CSF in multiple myeloma [PDF]

, 2003
High-dose chemotherapy with autologous peripheral blood stem cell transplantation is the standard treatment of patients with multiple myeloma today. In this study we used a combination mobilizing chemotherapy containing ifosfamide with G-CSF before stem ...
Werding, N., Straka, C., Adler-Reichel, S., Emmerich, B., Einsele, H., Hebart, H.   +5 more
core   +2 more sources

Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a global observational study [PDF]

, 2013
Fifty-five years after publication of the first hematopoietic stem cell transplantation this technique has become an accepted treatment option for defined hematologic and non-hematologic disorders.
Madrigal, Alejandro, Horowitz, Mary, Passweg, Jakob, Bouzas, Luis Fernando, Szer, Jeff, Niederwieser, Dietger, Gratwohl, Alois, Aljurf, Mahmoud, Iida, Minako, Kodera, Yoshihisa, Pasquini, Marcelo C., Marrow Transplantation,, Lipton, Jeff, Worldwide Network of Blood,, Gratwohl, Michael, Baldomero, Helen, Frauendorfer, Karl, Baldomero H, Niederwieser D, Horowitz M, Lipton J, Szer J, Kodera Y, Gratwohl M, Gratwohl A, Aljurf M, Iida M, Passweg J, Pasquini MC, Madrigal A, Bouzas LF, Frauendorfer K   +31 more
core   +1 more source

Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS

, 2001
Autologous hematopoietic stem cell transplantation (ASCT) has been recently utilized with encouraging results in patients with poorly controlled ...
A. Marmont, F. Sardanelli, M. Filippi, G. Meucci, A. Murialdo, M. Inglese, A. Lugaresi, G. L. Mancardi, R. Saccardi, F. Gualandi, M. P. Sormani, L. Massacesi, F. Pagliai, M. G. Marrosu, Pagliai F., Saccardi R., Meucci G., A. Marmont, the Italian GITMO NEURO Intergroup on Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis, TARTARO, Armando, LUGARESI, Alessandra, Massacesi, Luca, Lugaresi A., Massacesi L., Inglese M., Sormani M. P., FARINA, DEBORAH, Mancardi G. L., Gualandi F., Murialdo A., Sardanelli F., Filippi M., F. Pagliai, M. P. Sormani, Marmont A., Marrosu M. G.   +33 more
core   +2 more sources

Resveratrol enhances therapeutic effect on pancreatic regeneration in diabetes mellitus rats receiving autologous transplantation of adipose-derived stem cells

Chinese Journal of Physiology, 2020
Pancreatic damage is the major causative agent in type 1 diabetes mellitus (DM). Several strategies have been suggested to regenerate pancreatic functions, such as stem cell transplantation and administration of active components isolating from natural ...
Tung-Sheng Chen, Pei-Fang Lai, Chia-Hua Kuo, Cecilia Hsuan Day, Ray-Jade Chen, Tsung-Jung Ho, Yu-Lan Yeh, B Mahalakshmi, Vijaya Padmaviswanadha, Wei-Wen Kuo, Chih-Yang Huang   +10 more
doaj   +1 more source

Serum immunoglobulin levels in relation to levels of specific antibodies in allogeneic and autologous bone marrow transplant recipients

, 2000
BACKGROUND: The aim of this study was to investigate the correlation of total levels of immunoglobulins to levels of specific antibodies after allogeneic and autologous bone marrow transplantation.
Ringdén, O., Hammarström, Viera, Svensson, H., Pauksen, Karlis,, Lönnqvist, B., Simonsson, Bengt,, Ljungman, P.   +6 more
core   +5 more sources

Multiple Myeloma Patients at Various Cytogenetic Risks Benefit Differently from Autologous Stem Cell Transplantation as a Consolidation Therapy

Stem Cells International, 2015
Aim. To evaluate whether patients with multiple myeloma at various risks can still benefit the same from autologous stem cell transplantation consolidation in the era of novel agents.
Tianmei Zeng, Lili Zhou, Hao Xi, Weijun Fu, Juan Du, Chunyang Zhang, Hua Jiang, Jian Hou   +7 more
doaj   +1 more source

Autologous Transplantation for Older Adults with AML [PDF]

, 2018
While the majority of patients with acute myeloid leukemia (AML) are above the age of 65 years at diagnosis, the outcome of older AML patients remains disappointing.
Pabst, Thomas, Beatrice U. Mueller, Katja Seipel, Mueller, Beatrice, Thomas Pabst, Seipel, Katja, Bacher, Vera Ulrike, Ulrike Bacher, Bacher U, Pabst T, Seipel K, Mueller BU   +11 more
core   +2 more sources

The Incidence and Clinical Relevance of Graft Hypertrophy After Matrix-Based Autologous Chondrocyte Implantation [PDF]

, 2011
Background: Graft hypertrophy is the most common complication of periosteal autologous chondrocyte implantation (p-ACI). Purpose: The aim of this prospective study was to analyze the development, the incidence rate, and the persistence of graft ...
Matthias F. Pietschmann, Isa Feist-Pagenstert, Peter E. Müller, Volkmar Jansson, Horng, Annie, Müller, Peter E., Thomas R. Niethammer, Feist-Pagenstert, Isa, Jansson, Volkmar, Mehmet F. Gülecyüz, Pietschmann, Matthias F., Niethammer, Thomas R., Gülecyüz, Mehmet F., Annie Horng   +13 more
core   +1 more source

Autologous stem cell transplantation for malignancy: a systematic review of the literature

, 2000
A systematic review of the literature was undertaken to assess what published evidence is currently available to support the increasing use of autologous stem cell transplantation (ASCT), and to evaluate the published data with regard to the comparative ...
Simnett, S.J., Stewart, L. A., Johnson, Peter W.M., Morgan, G., Sweetenham, J.   +4 more
core   +2 more sources

Autologous Graft-versus-Tumor Effect: Reality or Fiction?

Advances in Hematology, 2016
In contrast to allogeneic hematopoietic stem cell transplantation, the current dogma is not an evidence of graft-versus-tumor effect in autologous hematopoietic stem cell transplantation; thus, it is assumed that autologous hematopoietic stem cell ...
Luis F. Porrata
doaj   +1 more source